Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis.
Synovitis is a key feature in osteoarthritis and is associated with symptom severity. Synovial membrane inflammation is secondary to cartilage degradation which occurs in the early stage and is located adjacent to cartilage damage. This inflammation is characterized by the invasion and activation of macrophages and lymphocytes, the release in the joint cavity of large amounts of pro-inflammatory and procatabolic mediators, and by a local increase of synovial membrane vascularity. This latter process plays an important role in the chronicity of the inflammatory reaction by facilitating the invasion of the synovium by immune cells. Therefore, synovial membrane angiogenesis represents a key target for the treatment of osteoarthritis. This paper is a narrative review of the literature referenced in PubMed during the past 5 years. It addresses in particular three questions. What are the mechanisms involved in synovium blood vessels invasion? Are current medications effective in controlling blood vessels formation and invasion? What are the perspectives of research in this area?
Bone and Cartilage Research Unit, Institute of Pathology, CHU Sart-Tilman, University of Liège, 4000 Liège, Belgium.
Yves
Y
Henrotin
Bone and Cartilage Research Unit, Institute of Pathology, University of Liège, Liège, Belgium.
Laurence
L
Pesesse
Bone and Cartilage Research Unit, Institute of Pathology, University of Liège, Liège, Belgium.
Cecile
C
Lambert
angiogenesis; arthritis; synovium; vascularization